FDA
-
-
-
-
-
-
-
Liquidia Technologies (LQDA) Announces Updates to Operations Leadership
-
-
-
-
-
-
-
Liquidia Corporation Announces $100 Million in New Financings
-
-
-
-
-
-
-
United Therapeutics Corporation Files Lawsuit Alleging Infringement of Tyvaso Patent Already Found to Be Invalid by U.S. Patent Office
-
-
-
-
-
-
-
Liquidia Corporation and Pharmosa Biopharm Announce Collaboration for Sustained-Release Inhaled Treprostinil Product in North America
-
-
-
-
-
-
-
Liquidia Corporation to Report First Quarter 2023 Financial Results on May 4, 2023
-
-
-
-
-
-
-
Liquidia Corporation to Report Full Year 2022 Financial Results on Thursday, March 16, 2023
-
-
-
-
-
-
-
Liquidia Announces Collaboration to Develop a New Infusion Pump for Subcutaneous Delivery of Treprostinil Injection to Treat Pulmonary Arterial Hypertension (PAH)
-
251,761 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All